Umoja Biopharma Appoints Dieter Weinand as the Chair of its Board of Directors
“We are extremely pleased to have Dieter join Umoja as the Chair of our Board of Directors.
- “We are extremely pleased to have Dieter join Umoja as the Chair of our Board of Directors.
- Dieter Weinand added, “With the ENLIGHTen clinical trial underway and Umoja positioned to advance its platforms through multiple collaborations in 2022, this is an exciting time to be joining the Company.
- He is currently Chairman of the Board of Replimune (REPL), Member of the Board of Directors of Reunion Neuroscience (REUN), Chairman of the Board of Directors of ForeBio, Chairman of the Board of Mnemo, and Executive Chairman of the Board of ZielBioPharma.
- This press release contains forward-looking statements about Umoja Biopharma, Inc. (the “Company,” “we,” “us,” or “our”).